Cresset Asset Management
HCAT icon

Cresset Asset Management’s Health Catalyst HCAT Stock Holding History

Cresset Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51K Buy
25,605
+15,000
+141% +$21.7K ﹤0.01% 1705
2026
Q1 		$13.5K Hold
10,605
– – ﹤0.01% 1605
2025
Q4 		$25.3K Hold
10,605
– – ﹤0.01% 1638
2025
Q3 		$30.2K Buy
+10,605
New +$36.3K ﹤0.01% 1544

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cresset Asset Management's HCAT Position: Q2 2026 in Review

Cresset Asset Management increased its Health Catalyst (HCAT) stake by 141% in Q2 2026, buying an estimated $21.7K and bringing the position to 25,605 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

Cresset Asset Management first reported a position in HCAT in Q3 2025 and has held it in 4 quarters since. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Cresset Asset Management held 25,605 shares of Health Catalyst worth $51K as of Q2 2026.
  • Cresset Asset Management bought 15,000 Health Catalyst shares in Q2 2026, an estimated $21.7K.
  • Health Catalyst made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1705 holding.
  • Cresset Asset Management first reported a position in Health Catalyst in Q3 2025 and has held it in 4 quarters since.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.